Polymer-mediated drug supersaturation - A spotlight on the interplay between phase-separated amorphous drug colloids and dissolved molecules.

Amorphous colloidal phase separation Colloid Freeze-fracture electron microscopy Kinetics Particle size distribution Precipitation Recrystallization Solid-state Supersaturation

Journal

Journal of colloid and interface science
ISSN: 1095-7103
Titre abrégé: J Colloid Interface Sci
Pays: United States
ID NLM: 0043125

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 28 01 2021
revised: 19 05 2021
accepted: 14 06 2021
pubmed: 2 7 2021
medline: 22 9 2021
entrez: 1 7 2021
Statut: ppublish

Résumé

Colloidal aggregation phenomena have been found responsible for the supersaturation of poorly water-soluble drugs, potentially leading to bioavailability enhancements. Unlike coarse precipitates, phase separation in the form of colloids, is expected to enhance drug supersaturation performance. Therefore, a high proportion of these colloids should correlate with the extent and the kinetics of supersaturation. The prime objective of the current study is to provide a mechanistic understanding on supersaturation for the model drug albendazole (ALB) in combination with twelve polymers. Species separated after a pH-shift were characterized by dynamic light scattering (DLS), freeze-fracture electron microscopy (FF-EM) and transmission X-ray diffraction (XRD). Laser diffraction (LD) in a liquid cell was introduced for a relative quantification of the colloidally separated species, described as colloid fraction. The pH-dependent supersaturation was assessed online using a miniaturized dissolution assay. Here, a measure of the extent of amorphous colloidal phase separation was established, and its impact on supersaturation was evaluated. As a result, a correlation was found between the extent of supersaturation and the colloid fraction. This confirmed the dependence of polymer-mediated enabling and preservation of supersaturation on the ability of polymers to stabilize colloid fractions. Furthermore, a fixed ratio was suggested between the dissolved drug and colloidally separated drug as the kinetic profiles of both species showed similar trajectories. In conclusion, colloid fractions were identified to be responsible for dissolved and potentially bioavailable drug molecules.

Identifiants

pubmed: 34197986
pii: S0021-9797(21)00963-2
doi: 10.1016/j.jcis.2021.06.089
pii:
doi:

Substances chimiques

Colloids 0
Polymers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

370-379

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ozan Hirlak (O)

Department of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, 53121 Bonn, Germany.

Sabine Dieluweit (S)

Institute of Biological Information Processing: IBI-2, Forschungszentrum Jülich, 52425 Jülich, Germany.

Rudolf Merkel (R)

Institute of Biological Information Processing: IBI-2, Forschungszentrum Jülich, 52425 Jülich, Germany.

Karl G Wagner (KG)

Department of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, 53121 Bonn, Germany. Electronic address: karl.wagner@uni-bonn.de.

Articles similaires

Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Semiconductors Photosynthesis Polymers Carbon Dioxide Bacteria
Animals Huntington Disease Mitochondria Neurons Mice
Inclusion Bodies Solubility Recombinant Proteins Detergents Protein Denaturation

Classifications MeSH